Details for New Drug Application (NDA): 050767
✉ Email this page to a colleague
The generic ingredient in CLEOCIN is clindamycin palmitate hydrochloride. There are three drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the clindamycin palmitate hydrochloride profile page.
Summary for 050767
| Tradename: | CLEOCIN |
| Applicant: | Pfizer |
| Ingredient: | clindamycin phosphate |
| Patents: | 0 |
Pharmacology for NDA: 050767
| Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Suppliers and Packaging for NDA: 050767
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CLEOCIN | clindamycin phosphate | SUPPOSITORY;VAGINAL | 050767 | NDA | Pharmacia & Upjohn Company LLC | 0009-7667 | 0009-7667-05 | 1 BLISTER PACK in 1 CARTON (0009-7667-05) / 3 SUPPOSITORY in 1 BLISTER PACK |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | SUPPOSITORY;VAGINAL | Strength | 100MG | ||||
| Approval Date: | Aug 13, 1999 | TE: | RLD: | Yes | |||||
Expired US Patents for NDA 050767
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Pfizer | CLEOCIN | clindamycin phosphate | SUPPOSITORY;VAGINAL | 050767-001 | Aug 13, 1999 | 6,495,157 | ⤷ Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription
